Late relapse in chronic hepatitis C after sustained viral response to interferon and ribavirin [1]

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 4, 2004, Pages 471-472

  Khokhar, Nasir ^a  

^a SHIFA INTERNATIONAL HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; RIBAVIRIN;

ADULT; ANTIVIRAL ACTIVITY; CASE REPORT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HEPATITIS C; HUMAN; LABORATORY TEST; LETTER; LIVER BIOPSY; LONG TERM CARE; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RNA ANALYSIS; VIRUS DIAGNOSIS; VIRUS INACTIVATION;

EID: 2342591933     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2004.03289.x     Document Type: Letter

References (5)

1. Collier JD, Adams PA, Feinman V et al. Long term follow up of patients with chronic hepatitis C treatment with inter-feron alfa. Can. J. Gastroenterol. 2000; 14 (Suppl. B): 77-80B.
2. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment and prevention of hepatitis C. Ann. Intern. Med. 2000; 132: 296-305.
3. Teuber G, Dienes HP, Meyer Zum KHB et al. Long term follow up of patients with chronic hepatitis C after interferon alfa treatment. Digestion 1996; 57: 464-71.
4. Yan FM, Chen AS, Hao F et al. Hepatitis C virus may infect extra hepatic tissues in patients with hepatitis C. World J. Gastroenterol. 2000; 6: 805-11.
5. Comanor L, Anderson F, Ghany M et al. Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at the end of treatment. Am. J. Gastroenterol. 2001; 96: 2968-72.